- VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study
[作者:Dimopoulos, MA; Richardson, PG; Schlag, R; Khuageva, NK; Shpilberg, O; Kastritis, E; Kropff, M; Petrucci, MT; Delforge, M; Alexeeva, J; Schots, R; Masszi, T; Mateos, MV; Deraedt, W; Liu, K; Cakana, A; van de Velde, H; Miguel, JFS,期刊:Journal of clinical oncology, 页码:6086-6093 , 文章类型: Article,,卷期:2009年27-36]
- Purpose To assess bortezomib plus melphalan and prednisone (VMP) and melphalan and prednisone (MP) in previously untreated patients with multiple myeloma (MM) with renal impairment enrolled on the phase III VISTA study, ...
- Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma
[作者:Goff, L; Summers, K; Iqbal, S; Kuhlmann, J; Kunz, M; Louton, T; Hagenbeek, A; Morschhauser, F; Putz, B; Lister, A; Rohatiner, A,期刊:Journal of clinical oncology, 页码:6094-6100 , 文章类型: Article,,卷期:2009年27-36]
- Purpose The randomized First-Line Indolent Trial (FIT) was conducted in patients with advanced follicular lymphoma (FL), to evaluate the safety and efficacy of yttrium-90 (Y-90) ibritumomab tiuxetan given as consolidatio...
- Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials Reply
[作者:Lennon, S; Barton, C; Banken, L; Gianni, L; Marty, M; Baselga, J; Leyland-Jones, B,期刊:Journal of clinical oncology, 页码:e274-e275 , 文章类型: Letter,,卷期:2009年27-36]
-
- Age-Related Variations in the Use of Axillary Staging May Explain the Increased Risk of Axillary Lymph Node Involvement in Older Women With Breast Cancer Reply
[作者:Wildiers, H; Van Calster, B; Van Dorpe, T; Dieudonne, AS; Smeets, A; Christiaens, MR; Neven, P,期刊:Journal of clinical oncology, 页码:e278-e278 , 文章类型: Letter,,卷期:2009年27-36]
-
- Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909
[作者:Damon, LE; Johnson, JL; Niedzwiecki, D; Cheson, BD; Hurd, DD; Bartlett, NL; LaCasce, AS; Blum, KA; Byrd, JC; Kelly, M; Stock, W; Linker, CA; Canellos, GP,期刊:Journal of clinical oncology, 页码:6101-6108 , 文章类型: Proceedings Paper,,卷期:2009年27-36]
- Purpose Mantle-cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin's lymphoma with a poor prognosis. We explored the feasibility, safety, and effectiveness of an aggressive immunochemotherapy treatment program that i...
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
[作者:Makishima, H; Cazzolli, H; Szpurka, H; Dunbar, A; Tiu, R; Huh, J; Muramatsu, H; O'Keefe, C; Hsi, E; Paquette, RL; Kojima, S; List, AF; Sekeres, MA; McDevitt, MA; Maciejewski, JP,期刊:Journal of clinical oncology, 页码:6109-6116 , 文章类型: Article,,卷期:2009年27-36]
- Purpose Acquired somatic uniparental disomy (UPD) is commonly observed in myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative neoplasms (MDS/MPN), or secondary acute myelogenous leukemia (sAML) and may po...
- Dose-Dense Adjuvant Doxorubicin and Cyclophosphamide Is Not Associated With Frequent Short-Term Changes in Left Ventricular Ejection Fraction
[作者:Morris, PG; Dickler, M; McArthur, HL; Traina, T; Sugarman, S; Lin, N; Moy, B; Come, S; Godfrey, L; Nulsen, B; Chen, C; Steingart, R; Rugo, H; Norton, L; Winer, E; Hudis, CA; Dang, CT,期刊:Journal of clinical oncology, 页码:6117-6123 , 文章类型: Article,,卷期:2009年27-36]
- Purpose Doxorubicin and cyclophosphamide (AC) every 3 weeks has been associated with frequent asymptomatic declines in left ventricular ejection fraction (LVEF). Dose-dense (dd) AC followed by paclitaxel (P) is superior ...
- Multimodality Screening of High-Risk Women: A Prospective Cohort Study
[作者:Weinstein, SP; Localio, AR; Conant, EF; Rosen, M; Thomas, KM; Schnall, MD,期刊:Journal of clinical oncology, 页码:6124-6128 , 文章类型: Article,,卷期:2009年27-36]
- Purpose Mammography has been established as the primary imaging screening method for breast cancer; however, the sensitivity of mammography is limited, especially in women with dense breast tissue. Given the limitations ...
|